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Valve diseases have a large share in the total morbidity and mortality of the adult population, and can 
be congenital or acquired. The last few decades have seen a predominance of degenerative (calcified) 
heart valve diseases due to a prolonged life expectancy in economically developed countries. The ther-
apeutic approach has remained unchanged and in the case of severe dysfunction, the valve is replaced 
with a mechanical or biological prosthesis, balloon valvuloplasty or valve reconstruction. The findings 
in understanding the development of heart valves along with human genome sequencing have led to 
the discovery of a genetic basis in valvular diseases1. Also, there are numerous evidence to suggest 
that heart valve diseases which develop in adulthood has its source in embryonic development. In this 
review authors will display the genetic basis of the two most common inherited valvular diseases: 
bicuspid aortic valve and mitral valve prolapse, as well as a review of the findings suggesting a genetic 
contribution to calcified aortic valve disease2. In addition, this review will include a review of the guide-
lines and benefits of genetic testing, as well as highlight the need to include genetic counseling in fami-
lies with proven or suspected malformations. Linking genetic information to the clinical phenotype 
(Table 1) and potential outcomes of surgical treatment leads to a personalized approach to each patient3.
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TABLE 1. Gene mutations associated with valvular heart disease.
Location Gene Inheritance Phenotype
Bicuspid aortic valve
Syndromic 17q24.3 KCNJ2 AD Andersen syndrome
Nonsyndromic 9q34.3
20q13.33
15q22.31
11q24.2
NOTCH1
GATA5
SMAD6
ROBO4
AD
AD, AR
AD
AD
AOVD1
CHTD5
AOVD2
AOVD3
Mitral valve prolapse
Syndromic 15q21.1
9q22.33
3p24.1
7q21.3, 12q13.1,
2q32.2,9q34.3
FBN1
TGFBR1
TGFBR2
Collagen types 
I–III, V/ XI
AD
AD
AD
AR,AD
AD,AD
Marfan syndrome
Loeys-Dietz syndrome 1
Loeys-Dietz syndrome2
OI 1,Ehlers-Danlos syndrome, cardiac 
valvular type
Nonsyndromic Xq28 Filamin A XL Cardiac valvular dysplasia
Aortic valve stenosis
CAVD 9q34.3 NOTCH1 AD AOVD1
AD – autosomal dominant, AR – autosomal recessive, AOVD – aortic valve disease, CHTD – congenital heart disease, OI – osteo-
genesis imperfecta, XL – X-linked, CAVD - calcified aortic valve disease.
